{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:31:57Z","timestamp":1790458317413,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21778003"],"award-info":[{"award-number":["21778003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00259-021-05212-7","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T22:31:30Z","timestamp":1613687490000},"page":"3113-3121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["18F-Boramino acid PET\/CT in healthy volunteers and glioma patients"],"prefix":"10.1007","volume":"48","author":[{"given":"Zhu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziren","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-4165","authenticated-orcid":false,"given":"Zhibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"5212_CR1","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1073\/pnas.1218165110","volume":"110","author":"EG Geier","year":"2013","unstructured":"Geier EG, Schlessinger A, Fan H, et al. Structure-based ligand discovery for the large-neutral amino acid transporter 1, LAT-1. Proc Natl Acad Sci U S A. 2013;110:5480\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5212_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/sj.bjc.6604235","volume":"98","author":"K Kaira","year":"2008","unstructured":"Kaira K, Oriuchi N, Imai H, et al. Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer. 2008;98:742\u20138.","journal-title":"Br J Cancer"},{"key":"5212_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6890-12-4","volume":"12","author":"Z Haining","year":"2012","unstructured":"Haining Z, Kawai N, Miyake K, et al. Relation of LAT1\/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas. BMC Clin Pathol. 2012;12:4.","journal-title":"BMC Clin Pathol"},{"key":"5212_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1227\/01.neu.0000316018.51292.19","volume":"62","author":"K Kobayashi","year":"2008","unstructured":"Kobayashi K, Ohnishi A, Promsuk J, et al. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery. 2008;62:493\u2013503 discussion 503-494.","journal-title":"Neurosurgery."},{"key":"5212_CR5","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/0008-5472.CAN-08-2345","volume":"69","author":"A Detta","year":"2009","unstructured":"Detta A, Cruickshank GS. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res. 2009;69:2126\u201332.","journal-title":"Cancer Res"},{"key":"5212_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803\u201320.","journal-title":"Acta Neuropathol"},{"key":"5212_CR7","doi-asserted-by":"publisher","first-page":"E6525","DOI":"10.1073\/pnas.1502648112","volume":"112","author":"Y Yang","year":"2015","unstructured":"Yang Y, Hernandez R, Rao J, et al. Targeting CD146 with a &lt;sup&gt;64&lt;\/sup&gt;Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas. Proc Natl Acad Sci U S A. 2015;112:E6525.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5212_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","volume":"1514","author":"O Yanagida","year":"2001","unstructured":"Yanagida O, Kanai Y, Chairoungdua A, et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta. 2001;1514:291\u2013302.","journal-title":"Biochim Biophys Acta"},{"key":"5212_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11095-020-02826-8","volume":"37","author":"E Puris","year":"2020","unstructured":"Puris E, Gynther M, Auriola S, Huttunen KM. L-type amino acid transporter 1 as a target for drug delivery. Pharm Res. 2020;37:88.","journal-title":"Pharm Res"},{"key":"5212_CR10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.2967\/jnumed.117.202267","volume":"59","author":"L Papp","year":"2018","unstructured":"Papp L, P\u00f6tsch N, Grahovac M, et al. Glioma survival prediction with combined analysis of in vivo 11C-MET PET features, ex vivo features, and patient features by supervised machine learning. J Nucl Med. 2018;59:892\u20139.","journal-title":"J Nucl Med"},{"key":"5212_CR11","first-page":"904","volume":"47","author":"W Chen","year":"2006","unstructured":"Chen W, Silverman DH, Delaloye S, et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47:904\u201311.","journal-title":"J Nucl Med"},{"key":"5212_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2967\/jnumed.112.109603","volume":"54","author":"M Rapp","year":"2013","unstructured":"Rapp M, Heinzel A, Galldiks N, et al. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. J Nucl Med. 2013;54:229\u201335.","journal-title":"J Nucl Med"},{"key":"5212_CR13","doi-asserted-by":"publisher","first-page":"13094","DOI":"10.1021\/ja053293a","volume":"127","author":"R Ting","year":"2005","unstructured":"Ting R, Adam MJ, Ruth TJ, Perrin DM. Arylfluoroborates and alkylfluorosilicates as potential PET imaging agents: high-yielding aqueous biomolecular 18F-labeling. J Am Chem Soc. 2005;127:13094\u20135.","journal-title":"J Am Chem Soc"},{"key":"5212_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.nucmedbio.2013.05.002","volume":"40","author":"Z Liu","year":"2013","unstructured":"Liu Z, Li Y, Lozada J, et al. Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging. Nucl Med Biol. 2013;40:841\u20139.","journal-title":"Nucl Med Biol"},{"key":"5212_CR15","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1002\/anie.201406258","volume":"53","author":"Z Liu","year":"2014","unstructured":"Liu Z, Pourghiasian M, Radtke MA, et al. An organotrifluoroborate for broadly applicable one-step 18F-labeling. Angew Chem Int Ed Eng. 2014;53:11876\u201380.","journal-title":"Angew Chem Int Ed Eng"},{"key":"5212_CR16","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.2967\/jnumed.114.153288","volume":"56","author":"J Lau","year":"2015","unstructured":"Lau J, Liu Z, Lin KS, et al. Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging. J Nucl Med. 2015;56:1434\u201340.","journal-title":"J Nucl Med"},{"key":"5212_CR17","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/anie.201208551","volume":"52","author":"Z Liu","year":"2013","unstructured":"Liu Z, Li Y, Lozada J, et al. Stoichiometric leverage: rapid 18F-aryltrifluoroborate radiosynthesis at high specific activity for click conjugation. Angew Chem Int Ed Eng. 2013;52:2303\u20137.","journal-title":"Angew Chem Int Ed Eng"},{"key":"5212_CR18","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nprot.2015.090","volume":"10","author":"Z Liu","year":"2015","unstructured":"Liu Z, Lin KS, B\u00e9nard F, et al. One-step (18)F labeling of biomolecules using organotrifluoroborates. Nat Protoc. 2015;10:1423\u201332.","journal-title":"Nat Protoc"},{"key":"5212_CR19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2967\/jnumed.114.137836","volume":"55","author":"Z Liu","year":"2014","unstructured":"Liu Z, Pourghiasian M, B\u00e9nard F, Pan J, Lin KS, Perrin DM. Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging. J Nucl Med. 2014;55:1499\u2013505.","journal-title":"J Nucl Med"},{"key":"5212_CR20","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1021\/acs.molpharmaceut.9b00891","volume":"16","author":"J Chen","year":"2019","unstructured":"Chen J, Li C, Hong H, et al. Side chain optimization remarkably enhances the in vivo stability of (18)F-labeled glutamine for tumor imaging. Mol Pharm. 2019;16:5035\u201341.","journal-title":"Mol Pharm"},{"key":"5212_CR21","doi-asserted-by":"publisher","first-page":"e1500694","DOI":"10.1126\/sciadv.1500694","volume":"1","author":"Z Liu","year":"2015","unstructured":"Liu Z, Chen H, Chen K, et al. Boramino acid as a marker for amino acid transporters. Sci Adv. 2015;1:e1500694.","journal-title":"Sci Adv"},{"key":"5212_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00259-017-3910-2","volume":"45","author":"X Yang","year":"2018","unstructured":"Yang X, Liu Z, Zhang H, et al. Preclinical evaluation of an (18)F-trifluoroborate methionine derivative for glioma imaging. Eur J Nucl Med Mol Imaging. 2018;45:585\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5212_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1021\/acs.molpharmaceut.7b00884","volume":"15","author":"H Liu","year":"2018","unstructured":"Liu H, Han Y, Li J, et al. (18)F-alanine derivative serves as an ASCT2 marker for cancer imaging. Mol Pharm. 2018;15:947\u201354.","journal-title":"Mol Pharm"},{"key":"5212_CR24","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1021\/acs.bioconjchem.9b00578","volume":"30","author":"J Li","year":"2019","unstructured":"Li J, Shi Y, Zhang Z, et al. A metabolically stable boron-derived tyrosine serves as a theranostic agent for positron emission tomography guided boron neutron capture therapy. Bioconjug Chem. 2019;30:2870\u20138.","journal-title":"Bioconjug Chem"},{"key":"5212_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","volume":"579","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang Y, Ding J, et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature. 2020;579:421\u20136.","journal-title":"Nature."},{"key":"5212_CR26","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023\u20137.","journal-title":"J Nucl Med"},{"key":"5212_CR27","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2967\/jnumed.113.133843","volume":"55","author":"RM Kessler","year":"2014","unstructured":"Kessler RM, Seibyl J, Cowan RL, et al. Radiation dosimetry of (18)F-FPEB in humans. J Nucl Med. 2014;55:1119\u201321.","journal-title":"J Nucl Med"},{"key":"5212_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1148\/radiol.11101139","volume":"260","author":"ES Mittra","year":"2011","unstructured":"Mittra ES, Goris ML, Iagaru AH, et al. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging \u03b1(v)\u03b2(3) integrin levels. Radiology. 2011;260:182\u201391.","journal-title":"Radiology."},{"key":"5212_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nature18610","volume":"535","author":"S Cuylen","year":"2016","unstructured":"Cuylen S, Blaukopf C, Politi AZ, et al. Ki-67 acts as a biological surfactant to disperse mitotic chromosomes. Nature. 2016;535:308\u201312.","journal-title":"Nature."},{"key":"5212_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02893360","volume":"12","author":"AL Johannessen","year":"2006","unstructured":"Johannessen AL, Torp SH. The clinical value of Ki-67\/MIB-1 labeling index in human astrocytomas. Pathol Oncol Res. 2006;12:143\u20137.","journal-title":"Pathol Oncol Res"},{"key":"5212_CR31","first-page":"262","volume":"23","author":"L Neder","year":"2004","unstructured":"Neder L, Colli BO, Machado HR, Carlotti CG Jr, Santos AC, Chimelli L. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study. Clin Neuropathol. 2004;23:262\u201370.","journal-title":"Clin Neuropathol"},{"key":"5212_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.7314\/APJCP.2015.16.2.411","volume":"16","author":"WJ Chen","year":"2015","unstructured":"Chen WJ, He DS, Tang RX, Ren FH, Chen G. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2015;16:411\u201320.","journal-title":"Asian Pac J Cancer Prev"},{"key":"5212_CR33","doi-asserted-by":"publisher","first-page":"815.e815","DOI":"10.1016\/j.crad.2019.06.019","volume":"74","author":"Z Kong","year":"2019","unstructured":"Kong Z, Li J, Liu Z, et al. Radiomics signature based on FDG-PET predicts proliferative activity in primary glioma. Clin Radiol. 2019;74:815.e815\u201323.","journal-title":"Clin Radiol"},{"key":"5212_CR34","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00259-019-04407-3","volume":"46","author":"F Liesche","year":"2019","unstructured":"Liesche F, Lukas M, Preibisch C, et al. (18)F-Fluoroethyl-tyrosine uptake is correlated with amino acid transport and neovascularization in treatment-naive glioblastomas. Eur J Nucl Med Mol Imaging. 2019;46:2163\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5212_CR35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/RLU.0000000000002654","volume":"44","author":"AH Katsanos","year":"2019","unstructured":"Katsanos AH, Alexiou GA, Fotopoulos AD, Jabbour P, Kyritsis AP, Sioka C. Performance of 18F-FDG, 11C-methionine, and 18F-FET PET for glioma grading: a meta-analysis. Clin Nucl Med. 2019;44:864\u20139.","journal-title":"Clin Nucl Med"},{"key":"5212_CR36","doi-asserted-by":"publisher","first-page":"14760","DOI":"10.1038\/s41598-018-33034-5","volume":"8","author":"C Debus","year":"2018","unstructured":"Debus C, Afshar-Oromieh A, Floca R, et al. Feasibility and robustness of dynamic (18)F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation. Sci Rep. 2018;8:14760.","journal-title":"Sci Rep"},{"key":"5212_CR37","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2967\/jnumed.115.171033","volume":"57","author":"M Unterrainer","year":"2016","unstructured":"Unterrainer M, Schweisthal F, Suchorska B, et al. Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma: does it make sense? J Nucl Med. 2016;57:1177\u201382.","journal-title":"J Nucl Med"},{"key":"5212_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00726-014-1863-3","volume":"47","author":"A Habermeier","year":"2015","unstructured":"Habermeier A, Graf J, Sandh\u00f6fer BF, Boissel JP, Roesch F, Closs EI. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET). Amino Acids. 2015;47:335\u201344.","journal-title":"Amino Acids"},{"key":"5212_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/neuonc\/nov148","volume":"18","author":"V Dunet","year":"2016","unstructured":"Dunet V, Pomoni A, Hottinger A, Nicod-Lalonde M, Prior JO. Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis. Neuro-Oncology. 2016;18:426\u201334.","journal-title":"Neuro-Oncology"},{"key":"5212_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/cas.12602","volume":"106","author":"P Wongthai","year":"2015","unstructured":"Wongthai P, Hagiwara K, Miyoshi Y, et al. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2. Cancer Sci. 2015;106:279\u201386.","journal-title":"Cancer Sci"},{"key":"5212_CR41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ijrobp.2010.07.002","volume":"81","author":"AL Grosu","year":"2011","unstructured":"Grosu AL, Astner ST, Riedel E, et al. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys. 2011;81:1049\u201358.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5212_CR42","first-page":"432","volume":"42","author":"PL Jager","year":"2001","unstructured":"Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42:432\u201345.","journal-title":"J Nucl Med"},{"key":"5212_CR43","first-page":"312","volume":"3","author":"F Chen","year":"2013","unstructured":"Chen F, Zhang Y, Cai W. Molecular MRI of VEGFR-2 reveals intra-tumor and inter-tumor heterogeneity. Am J Nucl Med Mol Imaging. 2013;3:312\u20136.","journal-title":"Am J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05212-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T05:04:13Z","timestamp":1631077453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05212-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5212"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05212-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"3 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}